ISBN: 9798187049547 - what science says about... fenbendazole: the evidence-first guide to the unexplained (what science says about... cancer and the body - volume 8) (6 Ergebnisse)

Taschenbuch. Zustand: Neu. Neuware.

Paperback. Zustand: new. Paperback. A dog dewormer that fights cancer - or a viral story science can't yet confirm?Fenbendazole was developed to clear intestinal worms from livestock. It was never meant for oncology. Yet it belongs to a drug family that targets tubulin - the same protein exploited by some of medicine's most established chemotherapy agents - and laboratory evidence of its effects on cancer cells is real, replicated, and taken seriously by researchers.What science reveals is more complicated than either believers or skeptics tend to allow. The clinical evidence gap is not a conspiracy; it is a structural consequence of patent economics. The preclinical signal is genuine but bounded. And the distance between mechanism and therapy has swallowed far more promising compounds than this one.Inside, you'll discover: - Why fenbendazole's mechanism is scientifically credible - and why credibility is not the same as proof- What the laboratory studies actually showed, and where their findings stop- Why the question remains genuinely open, and what answering it would requireWhat Science Says About. is a series for readers who want evidence, not certainty - explore the full collection.Read it before drawing conclusions. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

PAP. Zustand: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

PAP. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Zustand: New. Print on Demand.

Paperback. Zustand: new. Paperback. A dog dewormer that fights cancer - or a viral story science can't yet confirm?Fenbendazole was developed to clear intestinal worms from livestock. It was never meant for oncology. Yet it belongs to a drug family that targets tubulin - the same protein exploited by some of medicine's most established chemotherapy agents - and laboratory evidence of its effects on cancer cells is real, replicated, and taken seriously by researchers.What science reveals is more complicated than either believers or skeptics tend to allow. The clinical evidence gap is not a conspiracy; it is a structural consequence of patent economics. The preclinical signal is genuine but bounded. And the distance between mechanism and therapy has swallowed far more promising compounds than this one.Inside, you'll discover: - Why fenbendazole's mechanism is scientifically credible - and why credibility is not the same as proof- What the laboratory studies actually showed, and where their findings stop- Why the question remains genuinely open, and what answering it would requireWhat Science Says About. is a series for readers who want evidence, not certainty - explore the full collection.Read it before drawing conclusions. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…